Some studies have reported on the differences in amino-weighted CEST contrast values between IDH-mutant and IDH-wildtype gliomas [23,30,31,32], between astrocytomas and oligodendrogliomas [33], and among the tumors of different WHO classification grades [34,35]. This evidence concerns the gene IDH2 and oligodendroglioma.